The accumulation of amyloid ␤ peptide(1-42) (A␤(1-42)) in extracellular plaques is one of the pathological hallmarks of Alzheimer disease (AD). Several studies have suggested that cellular reuptake of A␤(1-42) may be a crucial step in its cytotoxicity, but the uptake mechanism is not yet understood. A␤ may be present in an aggregated form prior to cellular uptake. Alternatively, monomeric peptide may enter the endocytic pathway and conditions in the endocytic compartments may induce the aggregation process. Our study aims to answer the question whether aggregate formation is a prerequisite or a consequence of A␤ endocytosis. We visualized aggregate formation of fluorescently labeled A␤(1-42) and tracked its internalization by human neuroblastoma cells and neurons. ␤-Sheet-rich A␤(1-42) aggregates entered the cells at low nanomolar concentration of A␤(1-42). In contrast, monomer uptake faced a concentration threshold and occurred only at concentrations and time scales that allowed A␤(1-42) aggregates to form. By uncoupling membrane binding from internalization, we found that A␤(1-42) monomers bound rapidly to the plasma membrane and formed aggregates there. These structures were subsequently taken up and accumulated in endocytic vesicles. This process correlated with metabolic inhibition. Our data therefore imply that the formation of ␤-sheet-rich aggregates is a prerequisite for A␤(1-42) uptake and cytotoxicity.
One of the pathological hallmarks of Alzheimer disease (AD) 2 is the presence of extracellular plaques composed mainly of 42-amino acid amyloid ␤ peptide (A␤ ) (1) . The small hydrophobic A␤ peptide, which is generated by proteolytic cleavage of the amyloid precursor protein, is released as a monomer from the plasma membrane into extracellular space, and tends to aggregate spontaneously into oligomeric, protofibrillar, and fibrillar assemblies (2) (3) (4) . Oligomeric species of A␤ are tightly linked to AD pathogenesis and are presumed to be the cause of neuronal damage (5) . Several studies have suggested that the reuptake of extracellular A␤ into neurons may lead to the formation of intracellular aggregates, resulting in neuronal damage and neurotoxicity (6 -8) . Endocytosis of misfolded proteins has also been observed in cell models of the tau protein, ␣-synuclein and huntingtin (9, 10) , and recent evidence suggests that it may be the initial step in the replication of the misfolded protein structures by prion mechanisms (10 -14) . Several possible endocytic pathways, such as macropinocytosis and receptor-mediated endocytosis, have been discussed for A␤ and other misfolded protein aggregates (15) (16) (17) (18) (19) . However, our understanding of the connection between aggregation and cytotoxicity is still limited. It has not been conclusively determined how and when the A␤(1-42) peptide becomes toxic, whether A␤ aggregates prior to internalization or during the internalization process and, if so, in which intracellular compartments the aggregates form. Elucidating the connection between aggregation and internalization of A␤ peptide may be thus vital in understanding its toxicity. Here, we examine the relationship between the aggregation state of extracellular A␤ and the efficiency of its internalization. We aimed to determine whether the formation of aggregates and particularly ␤-sheet-rich structures, as reported by thioflavin dyes (20) and conformation-specific antibodies is a prerequisite for its neuronal uptake.
We found that cultured human neuroblastoma cells (SH-EP cells) can efficiently internalize ␤-sheet-rich aggregates of A␤ at nanomolar concentrations, and that cellular uptake was associated with metabolic inhibition. In contrast, monomeric A␤ only entered cells inefficiently and at high nanomolar concentrations. Internalization occurred after aggregation on the plasma membrane, which suggests that the membrane is an environment that facilitates aggregation of A␤ monomers.
Results

Preparation and Characterization of Fluorescently Labeled
A␤ -To investigate the relationship between the aggregation state of A␤ , its internalization and cytotoxicity, we examined whether the presence of the secondary structure determines the behavior of A␤ toward the cells and membranes. Aggregated A␤, which may contain oligomers, protofibrils, and fibrils, was classified in two populations: a state without ␤-sheet structure and a state in which ␤-sheets have been formed. Concentrations of aggregated A␤ peptide are expressed in terms of their amount of A␤ monomers as "equivalent monomer concentration."
To track the peptide and to observe aggregation of monomeric A␤ in cultured cells, we generated A␤ peptides that were fluorescently labeled at the N terminus with Atto565-maleimide (A␤ 565 ), Atto488-maleimide (A␤(1-42) 488 ), or Atto633-maleimide (A␤(1-42) 633 ) as described below. Labeled A␤ was separated by size exclusion chromatography (SEC, Fig. 1A ). A␤ eluted in two populations at 0.86 (protofibrils, PF) and 1.39 ml (monomer, M).
We used unlabeled monomers and aggregation-incompetent sc-A␤ 565 as controls on SEC, both of which eluted similar to the A␤ 565 monomer fraction (M, Fig. 1A ). Those monomers could not be detected by atomic force microscopy (AFM, Fig. 1B ). In contrast, AFM identified the PF fraction of A␤ 565 to be protofibrils with an average height of 4 nm (Fig. 1B ). When incubated with ThT, the protofibrils (35 M monomer equivalent) bound the dye immediately and ThT fluorescence changed little over the course of 1 h, whereas ThT fluorescence of the monomeric A␤ (35 M) displayed sigmoid kinetics typical of nucleated polymerization (Fig. 1C) .
To further examine whether the fluorescence label influenced A␤(1-42) monomer aggregation, we compared fibril formation kinetics and fibril morphologies of labeled and unlabeled A␤ . Unlabeled monomeric A␤(1-42) was mixed with 10% A␤ 565 (total A␤(1-42) concentration of 15 M) and incubated in PBS at 25°C. Aggregation kinetics were monitored by binding of ThT in vitro (Fig. 1D) (21) . The addition of 10% A␤ 565 monomer slowed the formation of fibers only slightly, without changing fibril structure, as observed by AFM (Fig. 1, D and E) . We imaged fibrils formed in the presence of A␤ 633 by fluorescence microscopy using ThT fluorescence and A␤ 633 fluorescence (Fig. 1F) . A high degree of correlation between the signals in both channels demonstrated that all fibrils did indeed incorporate labeled A␤ (Fig. 1G) .
We used labeled monomers (M) and protofibrils (PF, Fig. 1B ) to compare their respective cellular uptake. Mature fibrils (Fig.  1E ) were used to compare their uptake to that of protofibrils and monomers. For kinetic analysis of cellular uptake mixtures of 90% unlabeled A␤ and 10% A␤ 565 were used. Efficient Uptake of A␤ Protofibrils-We treated cultured human neuroblastoma (SH-EP) cells with A␤ 565 monomers or protofibrils to determine whether both A␤ species are internalized differently. Cells were imaged by confocal microscopy after incubation with A␤ 565 at 37°C for 24 h (Fig. 2, A-E) . A soluble membrane-impermeable fluorescent dye, calcein (20 M) , was added to the extracellular medium to mark the uptake of extracellular medium during vesicular trafficking from the plasma membrane into the cells in endocytic vesicles (Fig. 3A) . Intracellular A␤ 565 could be detected after treatment with protofibrils (150 nM, Fig. 2A ) or with monomers at a higher concentration (500 nM, Fig. 2B ). Treatment with low concentrations of monomeric A␤ 565 (150 nM, Fig. 2C ) or with an aggregation-incompetent scrambled peptide, sc-A␤ 565 (500 nM, Fig. 2D ), did not lead to detectable A␤ 565 inclusions, as was the case for untreated cells (Fig. 2E, n.c.) . Quantitative analysis of A␤ 565 fluorescence in the endocytic vesicles and in the cytosol revealed that a low level cytosolic A␤ 565 signal could be detected after treatment with protofibrils (150 nM) or high concentration (500 nM) monomeric A␤(1-42) but not at low monomer concentrations (150 nM). The A␤ 565 signal in the surrounding cytosol was about 30-fold lower than in the vesicles (Fig. 2F) . The lack of uptake of sc-A␤ 565 demonstrated that internalization was specific for the A␤(1-42) sequence and was not a result of the fluorescent label (Fig. 2D) .
We then verified that internalization of A␤ 565 into endocytic vesicles was also observed in primary hippocampal neurons (Fig. 3, A-C) . After incubating neurons with aggregated A␤ 565 (150 nM), monomeric A␤(1-42) 565 (150 or 500 nM), and calcein (20 M) at 37°C for 1 day, the uptake of A␤ 565 and the colocalization of internalized A␤ 565 and calcein were observed for aggregated A␤(1-42) (Fig.  3A) and for monomeric A␤ at 500 nM (Fig. 3B ), but not for monomeric A␤ at 150 nM (Fig. 3C ), supporting our results from the neuroblastoma cell model. On the images, internalized A␤ 565 shown in neurons (Fig. 3, A and B) and SH-EP cells (Fig. 2, A and B) seem different in quantity and distribution, which may be the result of the isolation of glia-free hippocampal neurons, or may reflect a general higher endocytic activity of neurons under the same experimental conditions.
To test whether exogenous fluorescence represented A␤ species, we co-stained cells with the anti-␤-amyloid antibody 6E10, which confirmed that Atto565 fluorescence indeed indicated the presence of A␤ (Fig. 3, D and E) . Conversely, 6E10 staining detected only endogenous amyloid precursor protein in the absence of A␤ 565 (Fig. 3F ). These results suggest that protofibrillar A␤ is taken up at lower concentrations than the monomers, and that an effective uptake of monomer may require A␤ to form an ordered aggregate structure prior to cellular uptake.
Uptake of Monomer Requires a Minimum A␤ Concentration-
To quantitatively analyze the dependence of monomer uptake on the concentration of A␤(1-42), we titrated the cells either with A␤(1-42) monomer or protofibrils at 15-1500 nM (equivalent monomer concentration), and quantified intracellular A␤ as a function of A␤ concentration by the fluorescence of labeled A␤(1-42) using HCS microscopy ( Fig. 4A) .
We tracked the amount of internalized A␤ as a function of time and found maximal intracellular A␤(1-42) signal after 24 h (Fig. 4B ). The treatment with monomeric A␤(1-42) (200 nM) did not result in cell death within 49 h (data not shown). We thus used 24 h incubation for subsequent HCS microscopy experiments. For monomeric A␤ , the total amount of intracellular A␤ as well as the number of aggregates and their area was proportional to A␤(1-42) monomer concentrations in the medium. No intracellular 565 was incubated in PBS for 2 days. Similar fibril structures were detected in both samples. F, fluorescence microscopy of A␤(1-42) aggregated in the absence or presence of 4% A␤ 633 detected by ThT and Atto633 fluorescence. G, Pearson correlation analysis of ϳ100 aggregates from three independent samples indicates that ThT and Atto633 fluorescence are highly correlated in labeled A␤ fibrils; all scale bars, 1 m; *** indicates p Ͻ 0.001.
A␤ was observed at concentrations of 150 nM and below (Fig. 4, C and D) . In contrast, no such threshold concentration existed for the internalization of preformed A␤ 565 aggregates (Fig. 4, E and F) . The observed threshold concentration for monomer uptake is similar to the critical concentration (22) that was reported for the 565 (sc, 500 nM); and E, negative control (n.c.). Scale bars, 10 m. F, average fluorescence intensities per pixel inside endocytic vesicles, in the cytosol and in the extracellular space were calculated from the 565 nm channel of confocal images in A-E. Bar graphs represent average values Ϯ S.D. from image areas corresponding to endocytic vesicles marked by calcein (n ϭ 10), or from areas in the cytosol without vesicles (n ϭ 3) or in the extracellular space (n ϭ 3), respectively. Only cells treated with aggregated A␤ 565 (150 nM; PF, 150) or monomeric A␤(1-42) 565 (500 nM; M.500) displayed fluorescence above the background of untreated cells (n.c.), whereas those treated with A␤ 565 monomers at 150 nM (M.150) and sc-A␤(1-42) 565 (500 nM; sc.500) did not. Inset, cells treated under conditions that resulted in uptake of A␤ 565 aggregates displayed a 3-fold increase in cytosolic A␤ 565 signal compared with the extracellular space. A␤ 565 fluorescence in the cytosol is ϳ30-fold lower than inside the vesicles. G, Pearson correlation analysis of colocalization between calcein and A␤ 565 fluorescence in panels A-E. Bars indicate average R values of three regions of interest Ϯ S.D., ***, indicates p Ͻ 0.001; **, p Ͻ 0.007.
aggregation of A␤(1-42) monomers, which suggests that aggregation may be a prerequisite for uptake. Alternatively, differences in the degradation of A␤(1-42) by proteases, either extracellular prior to uptake or intracellular, could cause the higher amount of A␤ in the cells. To test this alternative hypothesis, we monitored concentrations of A␤ in the cell culture media and in cell lysates as a function of time by immunoblotting (Fig. 4 , G and H). We observed a pronounced increase of A␤ in the lysates of cells incubated with aggregated A␤(1-42) (500 nM) and a smaller increase in cells incubated with monomer (500 nM) after 24 h, mirroring the results from HCS microscopy ( Fig. 4B) . We then monitored the A␤(1-42) concentration in the culture media, either in the presence of cells or in control samples that were incubated without cells for 24 h. When monitoring the A␤(1-42) concentration in the culture media, no decrease of A␤(1-42) over time was observed for monomeric A␤ in the presence of cells or for either form of A␤ in the control samples without cells. These data indicate that monomeric A␤(1-42) is not degraded by proteases in the media, which would prevent its uptake. Rather, only the concentrations of aggregated A␤ were reduced substantially over time, likely reflecting its more efficient binding to, and uptake into cells. Taken together, these data strongly support our initial hypothesis that uptake of A␤(1-42) does indeed depend on its aggregation state. If so, it would be important to determine the type of aggregates that are efficiently taken up by the cells.
Efficient Uptake Correlates with Formation of ␤-Sheet-rich Aggregates-To determine which A␤ species could be efficiently taken up, we combined in vitro aggregation kinetics and cellular uptake experiments. A␤(1-42) amyloid formation was monitored in vitro to collect A␤(1-42) species at different 565 at 150 nM (A), monomeric A␤ 565 at 500 nM (B), or monomeric A␤ 565 at 150 nM concentration (C). Nuclei were stained by Hoechst 33342 (blue), endocytic vesicles were stained with calcein (green). D-F, co-staining of the internalized A␤(1-42) with anti-␤-amyloid antibody. SH-EP cells were incubated with A␤ 565 (500 nM, equivalent monomer concentration) (D and E), or Atto 565 dye (F) at 37°C for 24 h. Fixed cells were co-stained by anti-A␤ antibody (6E10) by IF staining, visualized by Cy5-conjugated secondary antibody (cyan), and imaged by confocal microscopy. Cell nuclei were stained with Hoechst 33342 (blue). D, internalized A␤ 565 was co-stained by 6E10/Cy5. E, no secondary antibody bound without primary antibody (6E10) to A␤ 565 . F, Atto565 dye was not taken up, and 6E10/Cy5 did not mark dye molecules; scale bars, 10 m. aggregates. Left, cell nuclei were stained with Hoechst 33342 (white). Nuclei, which locate in focus plane, were identified by the image analysis software (blue contour lines). Right, the software identification of nuclei (blue contour lines) in the cell bodies (red contour lines) and A␤ 565 aggregates inside the cell bodies (yellow spots); scale bars, 100 m. B, SH-EP cells were incubated with purified A␤ 565 monomer (200 nM) at 37°C from 1 to 49 h. Intracellular A␤ 565 in fixed cells was analyzed by HCS microscopy. Maximal intracellular A␤(1-42) was reached after 27 h. C-F, SH-EP cells were incubated with A␤ 565 monomer (C and D) or aggregates (E and F) at 37°C for 24 h. Total fluorescence intensities A␤ 565 , cell number per well, the number of A␤ 565 aggregates per cell, and total aggregates area were plotted as functions of A␤ (1-42 (Fig. 5A ). Samples were collected at four time points that corresponded to different phases of peptide aggregation: initiation (t0), lag-phase (t1), growth phase (t2), and plateau phase (t3). The samples were characterized by CD spectroscopy (Fig. 5B) . Within the lag phase (t0 and t1), A␤(1-42) partially lost its disordered state. It adopted a ␤-sheet structure during the growth phase (t2 and t3) as indicated by a minimum at 218 nm in the CD spectra. When centrifuged at 200,000 ϫ g, soluble A␤(1-42) was lost during its growth phase (t2-t3, Fig. 5C ). To determine which of these aggregation states are efficiently taken up, the SH-EP cells were incubated with A␤ species (t0 -t3) at 37°C at 150 nM equivalent monomer concentration, which is below the threshold concentration of A␤ 565 monomer internalization (Fig. 4D ). After 24 h incubation, intracellular A␤(1-42) aggregates were quantified by HCS microscopy (Fig. 5D ). Intracellular A␤ 565 aggregates were detected in cells that had been treated with growth (t2) and the steady-state phase (t3) aggregates. In contrast, no uptake of A␤(1-42) peptides was observed with samples from the initiation (t0) and lag phase (t1) of the polymerization reaction. This suggests that ␤-sheet-rich A␤ aggregates are efficiently internalized, whereas unstructured monomers (t0) or small aggregates/oligomers (t1) without ␤-sheet structure are not.
HCS data from Fig. 4 , C and E, show that neither form, monomer or small aggregates, had a strong effect on the number of living cells, i.e. internalized A␤ 565 did not cause cell death within 24 h. We therefore analyzed cell metabolic activities by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction, which is a well established marker of early mitochondrial toxicity (23) .
A␤ aggregates formed during the growth phase (t2 and t3) were significantly more toxic than monomers (t0) and samples collected during the lag-phase (t1) and inhibited mitochondrial metabolic activity (Fig. 5E ). Under our experimental conditions A␤(1-42) monomers became cytotoxic only at concentrations above 150 nM (Fig. 5F) , a point at which they also underwent internalization (Fig. 4, C and D) .
It should be noted that the dilution to 150 nM might change the structure of A␤ in the medium from the structure recorded by CD at 15 M (Fig. 5B) . Nevertheless, at concentrations of 150 nM and below only A␤(1-42) that had previously formed ␤-sheet-rich structures (t2, t3) was efficiently internal- ized, whereas unstructured monomers (t0) or small aggregates (t1) without ␤-sheet structure were not. This suggests that it was indeed the ␤-sheet aggregates that were taken up, rather than a different A␤(1-42) species. The question whether the intracellular A␤(1-42) still had ␤-sheet structure will be addressed in detail below.
These data support the hypothesis that the formation of a ␤-sheet structure may be a prerequisite for efficient uptake and subsequent cytotoxicity of A␤ 
Multimerization on Plasma Membrane Precedes Uptake of A␤ -To investigate the location of aggregate formation and to better track the dynamics of monomer uptake, we repeated the uptake experiment under conditions that allowed us to separate in time A␤(1-42) membrane interaction from its uptake into the cell. The cells were cooled to 4°C, which slows down both A␤(1-42) aggregation and cell metabolism, and then were treated with A␤ at 4°C for 45 min. The cells were then washed with ice-cold PBS to remove unbound A␤ , and then restored at 37°C in fresh media (Fig. 6A) .
Under these conditions (4°C, 60 min), even at a higher monomer concentration of 1 M, A␤ 565 was located only on the plasma membrane and no uptake could be observed (Fig.  6B) . Calcein (20 M) uptake displayed that the cell still had some endocytic activity under these conditions. First, we tested whether monomeric A␤(1-42) assembles into larger species on the cell membrane. We incubated SH-EP cells with two types of fluorescently labeled monomeric A␤(1-42), A␤(1-42) 488 , and A␤(1-42) 633 . The self-assembly of A␤(1-42) into di-and multimeric species was quantified by FRET between both fluorophores. After preincubation at 4°C for 15 min, SH-EP cells were treated with monomeric A␤ 488 and A␤ 633 (500 nM total A␤(1-42) concentration) at 4°C for 45 min. Confocal imaging showed that both A␤ 488 and A␤ 633 accumulated at the plasma membrane (Fig. 6C) . A␤ 488 and A␤ 633 not only colocalized but also displayed a FRET signal, indicating direct interaction between the two-labeled A␤(1-42) species. These data demonstrate that at least a fraction of the monomeric A␤(1-42) peptides rapidly co-aggregated on the plasma membrane.
We then tested if those membrane-bound A␤(1-42) aggregates did indeed form on the plasma membrane and could be taken up after their aggregation. To do so, SH-EP cells were treated successively with monomeric A␤(1-42) 488 and A␤ 633 , each at 500 nM concentration. SH-EP cells were first only incubated with monomeric A␤ 488 at 4°C for 30 min, which was then washed off. After removing the unbound A␤ 488 , the cells were treated with A␤(1-42) 633 at 4°C for another 30 min. After that, the cells were washed again to remove unbound A␤ , incubated in fresh medium at 37°C for 3 h to permit internalization of A␤ , and imaged by confocal microscopy (Fig. 6D) . Both labeled A␤(1-42) species colocalized in the endocytic vesicles. The FRET signal indicates that both had formed di-or multimeric complexes. Because the washing step had removed all A␤(1-42) 488 from solution, we conclude that A␤(1-42) 488 interacted with A␤ 633 while located on the plasma membrane. The membranebound aggregates were then taken up by endocytosis after the cells were returned to 37°C.
To verify that the FRET signal is specific to physical interaction of A␤(1-42) monomers and is not an artifact of the label or of colocalization, we used transferrin (Tf) as a negative control. Tf binds to a membrane receptor and is internalized via clathrin-mediated endocytosis but does not aggregate on the membrane. After incubating the cells at 4°C with two types of fluorescent transferrin conjugates (Tf/A488 and Tf/A647), we observed colocalization of both Tf conjugates. However, the colocalization did not correspond to a FRET signal (Fig. 6E) . This strongly suggests that the FRET between A␤(1-42) molecules results from a specific physical interaction.
For a more comprehensive analysis of the membrane-assisted self-assembly and subsequent uptake of A␤(1-42) monomers, the cells were treated with monomeric A␤ 565 at various concentrations (0 -1600 nM) at 4°C for 45 min. Subsequently the temperature was raised to 37°C to permit internalization of A␤ and the cells were incubated in fresh medium for 24 h. Intracellular A␤ 565 was then quantified by HCS microscopy (Fig. 6F ). Intracellular A␤ 565 aggregate signals could be detected at A␤ 565 monomer concentrations above 200 nM, similar to the threshold concentration we previously observed for monomer uptake at 37°C (Fig. 4, B and C) . These data demonstrate that A␤(1-42) binds to the plasma membrane and forms aggregates prior to cellular uptake, that the cell membrane assisted A␤(1-42) self-assembly, and that uptake of monomeric A␤(1-42) requires a critical A␤(1-42) concentration for membrane-assisted uptake.
Conceivably, small A␤(1-42) aggregates that are competent for uptake could be forming in solution and then bind to the plasma membrane. However, a comparison of conditions and time scales of A␤(1-42) aggregation in solution with those of the membrane binding experiment makes this hypothesis less likely. Incubation of cells with A␤(1-42) monomer for 45 min at 500 nM was sufficient to initiate uptake. In contrast, ThT positive A␤(1-42) species did not form in solution under the same conditions within 3 h even at monomer concentrations of 1500 nM (Fig. 6G) .
Finally, we probed the complex formation of A␤(1-42) 488 and A␤ 633 (150 nM each) by FRET as a function of time (Fig. 6H) . Little FRET signal was observed within the first 3 h, supporting our conclusion that membrane binding coincides with, or precedes interaction at this peptide concentration. Conversely, no FRET signal was observed after the co-incubation of scrambled sc-A␤(1-42) 488 and A␤ 633 (150 nM each), reinforcing that interaction depends on the A␤ peptide sequence and not on the fluorescent label. Formation of FRETpositive species also coincided with the time course of A␤ aggregation in vitro (Fig. 6, G and H) , suggesting that the FRET signal results from multimeric aggregated A␤ species.
We therefore conclude that binding to the plasma membrane occurred within the lag-phase of ThT aggregation kinetics, well before the formation of ␤-sheet-rich aggregates. Because our previous experiment demonstrated that formation of ␤-sheet Aggregation Initiates A␤(1-42) Uptake SEPTEMBER 9, 2016 • VOLUME 291 • NUMBER 37
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structures in vitro correlated with efficient uptake (Fig. 5, B and C), these data suggest that A␤(1-42) peptides may convert into ␤-sheet aggregates on the membrane prior to uptake after soluble A␤ 565 peptides were removed. We therefore analyzed, whether intracellular A␤(1-42) contained ␤-sheet structures.
Internalized A␤ Contains ␤-Sheet-rich StructuresTo identify the secondary structure of internalized A␤ in the cultured cells, we stained cells with the amyloidophilic dye ThS and the anti-amyloid fibril antibody LOC after A␤ uptake. ThS is widely used to visualize ␤-sheet-rich amyloid structures in histology (20, 24) . It displays enhanced fluorescence emission on ␤-sheet binding, and has higher affinity and less pH sensitivity than ThT (20) . When pre-aggregated A␤(1-42) (t1-t3) is taken up, both ThS and LOC staining colocalize with A␤ 633 fluorescence confirming the presence of fibrillar aggregates (Fig. 7, A and B) . However, ThS and LOC signals after incubation with monomeric A␤(1-42) do not clearly demonstrate the presence of ␤-sheet rich fibrils (Fig. 7,  A and B) . This leaves open the possibility that the A␤(1-42) species detected by FRET have not yet formed ␤-sheet structures.
Our previous experiments found: (i) monomeric A␤(1-42) is internalized at concentrations above ϳ200 nM; (ii) A␤ (1-42) aggregates on the plasma membrane; and (iii) aggregates containing ␤-sheet structure were taken up very efficiently, all suggesting a conversion of monomeric A␤(1-42) into ␤-sheet structure during uptake.
To resolve whether this conversion occurs, we performed a competitive uptake experiment between monomer at a subcritical concentration (A␤ 565 , 150 nM), which was co-incubated with ␤-sheet aggregates (A␤ 633 , 900 nM). Both species were labeled with different fluorophores to track in which compartment both monomers and aggregates were found. In addition, ␤-sheet-rich structures were stained by ThS. According to our previous results, we would expect monomers to be taken up only if they converted into ␤-sheet-rich structures via co-aggregation with pre-formed aggregates and that internalized A␤(1-42) co-stains with ThS.
SH-EP cells were treated with A␤(1-42) 565 monomer (150 nM) at 4°C for 20 min. Monomeric A␤ was removed, and then cells were treated with A␤ 633 aggregates at 900 nM at 4°C for 20 min, washed with ice-cold cell culture medium, and stained with ThS at 4°C for 10 min. After that, the cells were further incubated in fresh cell culture medium with calcein (20 M) at 37°C for 1 h. After removing the calcein-rich medium, the cells were incubated in calcein-free medium at 37°C, and live cell images were taken by spinning disk confocal microscopy (Fig. 7C) .
A␤ 565 was observed in both states, ThS positive (Fig.  7C, circle 1) and ThS negative (Fig. 7C, circles 2 and 3) . In Fig.  7C , circles 1 and 2 show two structures that contained both A␤ 565 and A␤ 633 . However, only the ThS positive structure colocalized with calcein (Fig. 7C, circle 1) . In contrast, ThS negative structures did not colocalize with calcein and were thus not inside the endocytic vesicles (Fig. 7C, circle 2) . We quantified ThS fluorescence of A␤ 565 monomers that colocalized with A␤ 633 fibrils and with A␤ 565 structures that did not contain A␤ 633 (Fig. 7D ). Only A␤ 565 that had coaggregated with A␤(1-42) 633 fibrils (Fig. 7D, F(fibril) /F(mono) Ͼ5) stained strongly with ThS (p Ͻ 0.008). In contrast, A␤ 565 that had not coaggregated with A␤ 633 fibrils (Fig. 7D , F(fibril)/F(mono) Ͻ 5) did not colocalize with ThS. A␤ structures that did not colocalize with ThS were not internalized (Fig. 7C, circle 3) .
We quantitatively analyzed internalized and surface-bound species of monomeric A␤ from confocal live cell imaging (Fig.  7E ). All monomeric A␤ found inside the cell both colocalized with preaggregated A␤ fibrils and stained strongly with ThS, whereas ϳ 1 ⁄ 3 of surface-bound monomeric A␤ did not colocalize with fibrillar A␤ or stained with ThS. We did not find any monomeric A␤ that stained with ThS without colocalizing with fibrillar A␤ either inside the cells or on the cell surface under these experimental conditions. This means that subthreshold concentrations of A␤(1-42) monomers were capable of binding to the plasma membrane. However, co-aggregation into ␤-sheet-rich structures was needed for their efficient uptake into the cells.
Finally, we monitored the incorporation of A␤ monomers into ␤-sheet-rich aggregates on the surface of SH-EP cells by live cell FRET imaging (Fig. 7F, supplemental Fig. S1 ). Monomeric A␤ coaggregated with A␤ fibrils within 30 min into structures that also bound ThS. Taken together, these data strongly support our hypothesis, that aggregation into ␤-sheet structures facilitates the efficient uptake of A␤(1-42) by neuroblastoma cells via an endocytic mechanism.
A␤ Aggregate Uptake Is Clathrin Independent-The location of A␤ aggregates in endocytic vesicles raises the question by which endocytic pathway ␤-sheet-rich aggregates are internalized. Here we tested whether A␤ aggregates are internalized by clathrin-mediated endocytosis (CME). The CME pathway was blocked by lowering the temperature to 4°C (25) . Transferrin binds to the transferrin receptor on the plasma membrane and then can be internalized via coated pits. Fluorescent transferrin conjugates are therefore broadly used as markers for investigating the early phase of CME (25) (26) (27) (28) . At 4°C, transferrin only binds to its receptor on the plasma membrane, and will not be taken up (25) . Therefore, transferrin was used as specifically reported for inhibition of the CME pathway. However, it should be noted that at this temperature the fluidity of membrane is limited, which may also influence other endocytic mechanisms or the aggregation of A␤(1-42) (29, 30) .
Following incubation with monomeric and pre-aggregated A␤ 565 (150 nM, respectively) calcein (20 M) and transferrin (10 ng/ml) at 4°C for 45 min, SH-EP cells were fixed and imaged by confocal microscopy (Fig. 8, A and B) . Transferrin was located exclusively at the cell membrane, demonstrating that CME was efficiently inhibited. Under these conditions 1-42) . SH-EP cells were incubated with aggregation time points (t0 -t3; see Fig. 5A ) of A␤(1-42) (300 nM) for 3 h, after which A␤(1-42) was removed and the cells were washed and cultivated overnight, fixed, and stained. Internalized A␤(1-42) was stained with LOC (i-iv, green) or ThS (v-vii, green). The cell cytoskeleton was stained with phalloidin-568 (red) in panels i-iv. B, fluorescence of internalized A␤ 633 (t3, 150 nM) incubated for 6 h colocalized with ThS and LOC signals; scale bar, 10 m for all panels. C, live cell imaging of internalized A␤ . SH-EP cells were treated with A␤ 565 monomer (150 nM) and A␤ 633 aggregates (t3, 900 nM), at 4°C for 20 min each and stained with ThS. After removing unbound A␤ , the cells were incubated with calcein (20 M) at 37°C for 1 h. The live cell image was recorded by spinning disk confocal microscopy. Internalized aggregates that contained ␤-sheet structures showed positive ThS staining and positive calcein signals (circle 1). ThS negative A␤ 565 , colocalized with A␤(1-42) 633 (circle 2) or by itself (circle 3), was not taken up into endocytic vesicles and did not colocalize with calcein; scale bar, 10 m. D, box plot of colocalization of monomeric A␤ 565 with ThS in structures that either did or did not contain fibrillar A␤ 633 . Only A␤ 565 that had coaggregated with fibrillar A␤ 633 stained with ThS; n ϭ 10, p Ͻ 0.008. E, degree of colocalization of surface-bound and internalized A␤ 565 monomer with A␤(1-42) 633 fibrils. F, NFRET analysis of monomeric A␤(1-42) 555 (150 nM) and fibrillar A␤ 633 (150 nM) coaggregation in SH-EP cells acquired by sensitized emission of live cell images by confocal microscopy.
A␤(1-42) monomer was only observed on the plasma membrane and was not internalized. However, the A␤(1-42) on the membrane did not colocalize with transferrin. The uptake of pre-aggregated A␤(1-42) species was reduced but not totally inhibited under these conditions (Fig. 8A) . However, A␤ found in endocytic vesicles also did not colocalize with transferrin. These data suggest that uptake of A␤(1-42) is independent of CME. We then analyzed the internalization of A␤(1-42) 565 aggregates at 37°C under conditions that permitted CME. Endocytic markers were visualized by immunofluorescence staining (Fig.  9 ). No colocalization with clathrin ( Fig. 9A) and LAMP2 (Fig.  9B) was observed, supporting that A␤(1-42) was not internalized via CME. Rather, internalized A␤ 565 colocalized with caveolin ( Fig. 9C) and EEA1 (Fig. 9D) , confirming that A␤ 565 was localized in endocytic vesicles and were taken up in a CME-independent pathway.
Discussion
Taken together, our data allow us to map the first steps in A␤ internalization starting from the monomeric peptide. First, A␤(1-42) monomers or very early disordered oligomers bind rapidly to the plasma membrane. Their binding partner could be either the lipid bilayer itself or plasma membrane proteins. Numerous studies have demonstrated interaction of A␤ with lipid bilayers. Its role in A␤(1-42) uptake will be scrutinized in a future study. There, they aggregate either on the membrane surface itself or in a compartment that is very close to the membrane, from which they are taken up into endocytic vesicles. The highly efficient uptake of ␤-sheet-rich structures suggests that aggregation into, or co-aggregation with ␤-sheet aggregates occurs.
For A␤ monomers, the peptide concentration has to be sufficient to initiate the first two steps of the process, resulting in a threshold for internalization at the saturation concentration, or critical concentration, for A␤(1-42) aggregation (22) . In contrast, no concentration threshold exists for the internalization of preformed A␤ aggregates with ␤-sheet structure.
This has several implications for the possible mechanism of A␤ toxicity. In our experiments metabolic inhibition was directly correlated with the formation and uptake of ␤-sheet-rich aggregates. Aggregated species have been found to play a central role in A␤(1-42) toxicity, not all of which are large ␤-sheet-rich structures (5) . Although ␤-sheet-rich A␤ that was efficiently endocytosed and that inhibited mitochondrial activity could be pelleted at 200,000 ϫ g (Fig. 5) , very large aggregate structures were unable to enter the cell. Our data therefore suggest that neurons preferably take up ␤-sheet-rich oligomeric and protofibrillar structures of intermediate size. It is tempting to speculate that small oligomers may have a higher affinity to the plasma membrane than the monomeric peptide, facilitating the conversion to ␤-sheet-rich structures and subsequent internalization. Our results demonstrate that, unlike monomers, preexisting A␤ aggregates are internalized at low nanomolar concentrations, which corresponds to previously observed binding of A␤ oligomers to neuronal plasma membranes at nanomolar concentration (31, 32) .
Our experiments did not provide evidence that uptake of aggregates proceeds via CME. A␤ can enter the cells via a non-clathrin-mediated pathway, and then locate in the endocytic vesicles. Costaining with caveolin suggests a possible uptake route via the caveolin endocytosis pathway. A␤ is also believed to be involved in cholesterol and caveolin trafficking (33) .
A␤ aggregates may be taken up via receptor independent endocytosis, as had been observed previously (34) . Other pathways for the internalization of amyloidogenic proteins have been discussed. Synthetic peptide aggregates of sizes Ͻ500 nm were taken up into HEK cells by nonspecific endocytosis, whereas larger aggregates were internalized by a mechanism similar to phagocytosis (35) . Tau aggregates can be internalized via micropinocytosis, mediated by glycosaminoglycans (36) . It is possible that A␤ aggregates enter the cell by the same pathway.
Second, we found that A␤ aggregates can form in a concentration-dependent manner through self-assembly of A␤ on the plasma membrane and that internalized A␤ aggregates have ␤-sheet structure. It has long been known that lipid interaction promotes A␤(1-40) transition to ␤-sheet structure (37) and our data support the interpretation that this process is central to A␤ uptake and toxicity. Our data suggest the binding of A␤ to the lipid bilayer or to membrane proteins may be the first step in the formation of cytotoxic A␤(1-42) aggregates de novo. Factors that increase partitioning of A␤ to the plasma membrane will therefore likely promote the formation of ␤-sheet-rich aggregates on the membrane. These include lipid peroxidation products, such as secocholesterol and 4-hydroxy-nonenal that facilitate A␤ membrane binding and aggregation (38 -40) , divalent metal ions promoting A␤ membrane interaction (41) , and interaction with membrane proteins (16) . Our data support a central role of endocytosis in A␤ cytotoxicity (15) and provide strong evidence that aggregation precedes endocytosis, a question that had previously not been conclusively resolved (7, 8) . This experimental evidence may improve our understanding of AD pathology and may inform more focused therapeutic approaches targeting membrane binding and self-assembly of the A␤ peptide.
Experimental Procedures
Preparation of Monomers and Fluorescent Labeling of A␤ -Synthetic human A␤(1-42) and A␤(1-42) with a single N-terminal cysteine residue (Institute for Medical Immunology, Charité, Berlin, Germany) were dissolved in hexafluoro-2-propanol and incubated at room temperature overnight. After flash freezing by liquid nitrogen, hexafluoro-2-propanol was removed by lyophilization (Savant SpeedVac, Thermo), and the peptides were stored at Ϫ20°C until use.
To prepare unlabeled monomer, lyophilized A␤(1-42) was dissolved in 10 mM NaOH, sonicated for 30 min in ice-cold water bath, and passed through a 0.22-m and a 30-kDa filter (Millipore). The monomers were kept on ice and used immediately or within 1 h.
A␤(1-42) with a single N-terminal cysteine residue was labeled by Atto488-maleimide (A␤(1-42) 488 ), Atto565-maleimide (A␤ 565 ), or Atto 633-maleimide (A␤ 633 , Atto Tec) at a 1:1.5 M ratio in NaOH (10 mM) containing 0.05 mM Tris(2-carboxyethyl)phosphine, pH 7.5, and at 4°C overnight. A␤ 565 and free Atto565-maleimide were separated by SEC (Superdex 75, 3.2/20 column, GE Healthcare) with a flow rate at 40 l/min in 10 mM NaOH.
Scrambled-A␤(1-42) (Millipore, sc-A␤(1-42)) was dissolved in 10 mM NaOH and labeled with Atto565-NHS (sc-A␤ 565 ). The labeling process and the separation of sc-A␤ 565 and free dyes were the same as described above. A␤ labeled at the N terminus with Hylite555 (A␤ 555 , Anaspec) was monomerized as described above for unlabeled A␤ .
Monitoring Aggregation Kinetics of A␤ by ThT and SDS-PAGE-A␤(1-42) monomer aggregation assays were performed in PBS or 50 mM sodium phosphate, pH 7.4, as indicated, containing 20 M ThT in a microplate reader (InfinitE M200, Tecan, Austria) at 37°C. ThT fluorescence (excitation wavelength of 440 nm and emission wavelength of 485 nm) was measured every 5 min after 5 s shaking. 50 l of A␤(1-42) was removed at different time points as indicated and centrifuged for 30 min at 200,000 ϫ g (Beckman TL-100). Supernatants were analyzed by denaturing SDS-PAGE.
Circular Dichroism Spectroscopy-A␤(1-42) samples (15 M) in PBS were measured in a 1-mm path length cuvette. Circular dichroism (CD) spectra were recorded between 200 and 260 nm with a step size of 1 nm in a CD spectrometer (J-720, Jasco, Japan).
Atomic Force Microscopy-10-l samples were loaded onto freshly cleaved mica (mica was glued on a glass slide) for 5 min, washed with freshly filtered deionized water (3 ϫ 100 l), and dried overnight. All the images were taken using intermittent contact mode on a Nanowizard II/Zeiss Axiovert setup (JPK).
Cell Culture and Cellular Uptake-SH-EP cells were maintained in culture medium (10% (v/v) fetal bovine serum, 4 mM L-glutamine, 110 mg/liter of sodium pyruvate, 100 units/ml of penicillin-streptomycin, 4.5 g/liters of D-glucose in 500 ml of Dulbecco's modified Eagle's medium (Gibco)) at 37°C and 5% CO 2 . Cells were seeded into 96-well plates or 35-mm cell culture dishes (MatTek) and grown to about 80% confluence. For cellular uptake, the cells were incubated with A␤(1-42) or labeled A␤ at various concentrations, temperatures, and times. The cells were then washed twice with PBS and fixed with 3.7% paraformaldehyde for 10 min at room temperature. Primary rat hippocampal neurons were a gift of J. Meier, MDC Berlin, and prepared and cultured as previously described (42) .
Dot Blot Quantification of A␤-SH-EP cells were cultured as described above and seeded in a 96-well plate (10,000 cells/well) for quantification of A␤ in supernatant and in a 12-well plate (80,000 cells/well) for quantification of A␤ in cell lysate. Cells were incubated with monomeric A␤(1-42) or A␤(1-42) that was pre-aggregated to the t3 time point (Fig. 5A ) in sodium phosphate buffer (50 mM, pH 7.4) as indicated. Cells were washed in PBS, lysed in 100 l of Tris buffer (50 mM, pH 5.1) containing 2% SDS, and boiled for 10 min. 100 l of cell lysates or culture media was run through a nitrocellulose membrane (Bio-Rad) on a 96-well vacuum apparatus. Serial dilutions for monomeric and pre-aggregated A␤(1-42) were spotted in triplicate on the same membrane as the cell samples, and were used as standard reference for calculation of A␤ concentrations. The membrane was incubated with blocking buffer (5% BSA in PBS) for 1 h, was washed twice with PBS-T buffer (0.1% Tween 20 in PBS) for 10 min, and then incubated for 1 h with primary antibody, anti-␤-amyloid mouse monoclonal antibody (1:500, 6E10, Covance), followed by secondary antibody, IRDyeGAM-800CW (1:15,000, Li-Cor), in PBS-T buffer containing 0.5% BSA. Fluorescence of three replicate wells was evaluated through densitometry. A␤ concentrations were calculated from signals of reference dilution samples by linear regression analysis.
Thioflavin S Staining-Thioflavin S (ThS) was dissolved in 50% ethanol to 1 mg/ml, and stored at 4°C. Fixed cells were stained with 0.01% ThS for 5 min, washed 3 times with 70% ethanol; incubated with 0.25% KMnO 4 for 4 min, rinsed with water; incubated with 1% NaHBO 4 for 4 min; then incubated with 3ϫ PBS (411 mM NaCl, 8.1 mM KCl, 30 mM Na 2 HPO 4 , 5.2 mM KH 2 PO 4 , pH 7.2) at 4°C for 30 min and rinsed with water.
For live cell imaging, cells were incubated with ThS at 10 g/ml in cell culture medium at 37°C for 10 min. Then the cells were washed five times with PBS and kept in cell culture medium until microscopy.
ImmunofluorescenceStaining(IF)-Toexamineifthedyefluorescence of A␤ 565 accurately reports the formation of intracellular A␤ aggregates and their cellular locations, the cells were co-stained with anti-␤-amyloid mouse monoclonal antibody (6E10, Covance), polyclonal anti-amyloid fibril antibody LOC (1:800, Millipore), phalloidin-568 (1:500, Fisher), or endocytic markers by IF after treatment with A␤ 565 aggregates. The fixed cells were permeabilized with 0.5% Triton X-100 at room temperature for 5 min, washed twice with PBS. Then cells were incubated with blocking buffer (3% BSA in PBS) at room temperature for 1 h, and were incubated with primary and secondary antibody (diluted at 1:2000) in blocking buffer in the dark at room temperature for 1 h, respectively. The following primary antibodies for endocytic marker proteins were used: anti-caveolin-1 (Santa Cruz), anti-clathrin heavy chain (Abcam), anti-EEA1 (C45B10, Cell Signaling), and anti-
